T. Lerut
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
T. Lerut has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Dirk Van Raemdonck
Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium
18 shared publications W. Coosemans
Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium
9 shared publicationsP. De Leyn
Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium
8 shared publicationsW Coosemans
7 shared publications- G. Decker
Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium
5 shared publications - Geert M. Verleden
Dept of Respiratory Diseases, University Hospital Gasthuisberg, Leuven, Belgium
5 shared publications
Latest Publications
- 5 October 2016
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 30 (1) , 1-8
Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road
- 5 October 2016
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 30 (1) , 1-8
Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road
- Open Access
- 7 August 2015
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 21 (suppl_1) , S10-S11
F-036ISOLATED LOCAL RECURRENCE OF SOLITARY SOLID ORGAN METASTASIS AFTER OESOPHAGECTOMY FOR CANCER IS NOT THE END OF THE ROAD
Objectives: Recurrent disease after oesophagectomy bears an infaust prognosis, especially when multiple recurrences are present. But little is known about survival in limited recurrence (solitary locoregional or solid organ metastasis). Herein we report our experience with these subgroups.
- 7 August 2015
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 21 (suppl_1) , S10-S11
Open AccessF-036ISOLATED LOCAL RECURRENCE OF SOLITARY SOLID ORGAN METASTASIS AFTER OESOPHAGECTOMY FOR CANCER IS NOT THE END OF THE ROAD
Objectives: Recurrent disease after oesophagectomy bears an infaust prognosis, especially when multiple recurrences are present. But little is known about survival in limited recurrence (solitary locoregional or solid organ metastasis). Herein we report our experience with these subgroups.
- Open Access
- 1 July 2013
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (suppl_1) , S24
F-090SIGNET-RING CELLS IN OESOPHAGEAL AND GASTRO-OESOPHAGEAL JUNCTION CARCINOMAS HAVE A MORE AGGRESSIVE BIOLOGICAL BEHAVIOUR
In contrast with gastric cancer little is known about the biological behaviour and prognosis of signet-ring cells (SRC). To clarify the biological behaviour of oesophageal signet-ring-cell containing carcinomas (SRC), clinicopathological features were compared to non-SRC adenocarcinomas (ADC) of the oesophagus and gastro-oesophageal-junction (GEJ). Between 1990 and 2009, 779 patients underwent primary R0 resection. Specimens containing signet-ring cells were classified according to WHO criteria (>50% SRC or 50% SRC, 57 P < 0.001). In SRC 50% it was 16% (NS). Lymph node metastasis (pN+) was present in 438 patients with cancer-specific 5-year survival of 32% in ADC, 29% in SRC 50% (P = 0.010). The mean number of positive lymph nodes was not significantly different between ADC and SRC 50% (5.85 vs 8.89; P = 0.049). In ADC, 30% were pN3s (>6 positive LNs), not significantly different from pN3s in SRC 50% (61%, P = 0.006). SRC showed a higher recurrence rate (56% vs 42% for ADC; P = 0.003) in particular locoregional recurrences (29% vs 16%; P = 0.002). Locoregional recurrence was more prominent in SRC >50% (44%) vs SRC 50% (sensitivity = 60%, PPV = 50%). SRC are aggressive neoplasms carrying a worse prognosis compared to non-SRC ADC after primary oesophagectomy, which appears mainly related to the SRC >50% subgroup because of higher nodal stage (pN3) and increased locoregional recurrence, whereas pN + SRC 50%, presence of signet-ring cells in pre-treatment biopsies appear to be of no use to define treatment strategy or prognosis. All authors have declared no conflicts of interest.
- 1 July 2013
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (suppl_1) , S24
Open AccessF-090SIGNET-RING CELLS IN OESOPHAGEAL AND GASTRO-OESOPHAGEAL JUNCTION CARCINOMAS HAVE A MORE AGGRESSIVE BIOLOGICAL BEHAVIOUR
In contrast with gastric cancer little is known about the biological behaviour and prognosis of signet-ring cells (SRC). To clarify the biological behaviour of oesophageal signet-ring-cell containing carcinomas (SRC), clinicopathological features were compared to non-SRC adenocarcinomas (ADC) of the oesophagus and gastro-oesophageal-junction (GEJ). Between 1990 and 2009, 779 patients underwent primary R0 resection. Specimens containing signet-ring cells were classified according to WHO criteria (>50% SRC or 50% SRC, 57 P < 0.001). In SRC 50% it was 16% (NS). Lymph node metastasis (pN+) was present in 438 patients with cancer-specific 5-year survival of 32% in ADC, 29% in SRC 50% (P = 0.010). The mean number of positive lymph nodes was not significantly different between ADC and SRC 50% (5.85 vs 8.89; P = 0.049). In ADC, 30% were pN3s (>6 positive LNs), not significantly different from pN3s in SRC 50% (61%, P = 0.006). SRC showed a higher recurrence rate (56% vs 42% for ADC; P = 0.003) in particular locoregional recurrences (29% vs 16%; P = 0.002). Locoregional recurrence was more prominent in SRC >50% (44%) vs SRC 50% (sensitivity = 60%, PPV = 50%). SRC are aggressive neoplasms carrying a worse prognosis compared to non-SRC ADC after primary oesophagectomy, which appears mainly related to the SRC >50% subgroup because of higher nodal stage (pN3) and increased locoregional recurrence, whereas pN + SRC 50%, presence of signet-ring cells in pre-treatment biopsies appear to be of no use to define treatment strategy or prognosis. All authors have declared no conflicts of interest.
- Open Access
- 1 July 2013
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (suppl_1) , S15
F-055SEMIMECHANICAL ANASTOMOSIS VERSUS HAND-SEWN ANASTOMOSIS AFTER OESOPHAGECTOMY WITH GASTRIC TUBULISATION AND CERVICAL ANASTOMOSIS
Semimechanical side-to-side stapled anastomosis is thought to reduce frequency of leaks and strictures when using whole stomach. Scarce data are available when using gastric tubulisation. Two matched groups of patients, operated between 2005 and 2008, were retrieved receiving a cervical oesophagogastrostomy on gastric tubulisation: 92 semimechanical anastomoses (SMA), 41 hand-sewn anastomoses (HSA). EORTC QLC-30 and OES-18 questionnaires were used to score anastomosis related symptoms. A difference of 10 points or 10% was considered clinically significant. Overall incidence of anastomotic leaks was 4.5%. Leakage rate in SMA was 2.17% vs 4.88% in HSA (P = 0.587). Dilatation occurred in 30% of SMA and 61% of HSA (P < 0.001), 15% and 49% respectively needing ≥3 dilatations (P < 0.001). Both groups demonstrated an initial increase of dysphagia score, being steeper for patients with HSA (mean score 31 vs 26). At 3 months, dysphagia subscales revealed higher mean scores for solids (HSA 38 and SMA 31) than for semisolids (HSA 30 and SMA 20) and for liquids (HSA 25 and SMA 26). Dichotomized results in symptomatic/asymptomatic showed a significantly higher percentage of HSA patients (33%) being symptomatic for difficulties swallowing solids compared to SMA patients (22%). HSA patients also had a significantly higher score for swallowing saliva (30 vs 20). After 3 months, no more significant differences were seen, except for reflux at 1 year being 27 % in HSA vs 16% for SMA. Patients in both groups gave a similar global HRQL score at all timepoints. Semimechanical anastomosis results in better dysphagia scores for solids and semisolids and reduces significantly the need for dilatations, in particular repeat dilatations. The negative effect of dysphagia in the HSA group fades out over time, probably due to the treatment, i.e. dilatations. Semimechanical anastomosis can be safely used after gastric tubulisation thus allowing resection of the lesser curvature, an important oncologic principle for distal half tumours. All authors have declared no conflicts of interest.
- 1 July 2013
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (suppl_1) , S15
Open AccessF-055SEMIMECHANICAL ANASTOMOSIS VERSUS HAND-SEWN ANASTOMOSIS AFTER OESOPHAGECTOMY WITH GASTRIC TUBULISATION AND CERVICAL ANASTOMOSIS
Semimechanical side-to-side stapled anastomosis is thought to reduce frequency of leaks and strictures when using whole stomach. Scarce data are available when using gastric tubulisation. Two matched groups of patients, operated between 2005 and 2008, were retrieved receiving a cervical oesophagogastrostomy on gastric tubulisation: 92 semimechanical anastomoses (SMA), 41 hand-sewn anastomoses (HSA). EORTC QLC-30 and OES-18 questionnaires were used to score anastomosis related symptoms. A difference of 10 points or 10% was considered clinically significant. Overall incidence of anastomotic leaks was 4.5%. Leakage rate in SMA was 2.17% vs 4.88% in HSA (P = 0.587). Dilatation occurred in 30% of SMA and 61% of HSA (P < 0.001), 15% and 49% respectively needing ≥3 dilatations (P < 0.001). Both groups demonstrated an initial increase of dysphagia score, being steeper for patients with HSA (mean score 31 vs 26). At 3 months, dysphagia subscales revealed higher mean scores for solids (HSA 38 and SMA 31) than for semisolids (HSA 30 and SMA 20) and for liquids (HSA 25 and SMA 26). Dichotomized results in symptomatic/asymptomatic showed a significantly higher percentage of HSA patients (33%) being symptomatic for difficulties swallowing solids compared to SMA patients (22%). HSA patients also had a significantly higher score for swallowing saliva (30 vs 20). After 3 months, no more significant differences were seen, except for reflux at 1 year being 27 % in HSA vs 16% for SMA. Patients in both groups gave a similar global HRQL score at all timepoints. Semimechanical anastomosis results in better dysphagia scores for solids and semisolids and reduces significantly the need for dilatations, in particular repeat dilatations. The negative effect of dysphagia in the HSA group fades out over time, probably due to the treatment, i.e. dilatations. Semimechanical anastomosis can be safely used after gastric tubulisation thus allowing resection of the lesser curvature, an important oncologic principle for distal half tumours. All authors have declared no conflicts of interest.
- Open Access
- 1 July 2013
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (suppl_1) , S2
B-005CAN EXTRACAPSULAR LYMPH NODE INVOLVEMENT BE A TOOL TO FINETUNE PN1 FOR ADENOCARCINOMA IN INTERNATIONAL UNION AGAINST CANCER TNM 7TH EDITION?
The current (7th) International Union Against Cancer (UICC) pN staging system is based on the number of positive lymph nodes but does not take into consideration characteristics of the metastatic lymph nodes itself. The aim of the current study was to examine the prognostic value of extracapsular (EC-LNI) and intracapsular (IC-LNI) lymph node involvement in oesophageal cancer. From 1990-2010, 792 adenocarcinoma patients with primary R0 resection were retrieved from our prospective database. The number of resected lymph nodes, number of positive lymph nodes and number of EC-LNI/IC-LNI were determined. Extracapsular spread was defined as infiltration of cancer cells beyond the capsule of the positive lymph node. Four hundred and eight (51.5%) patients had positive lymph nodes. In 227 (55.6%) cases EC-LNI was detected. EC-LNI showed significantly worse cancer-specific 5-year survival compared to IC-LNI, 20.5% vs 40.7% (P < 0.0001). In the pN1-category (1 or 2 positive LNs–UICC stages IIB and IIIA) this was 30.2% vs 48.8%; P = 0.0035). In higher UICC stages, this effect was no longer noticed. UICC stages IIB/IIIA, EC-LNI patients show survival rates that are more closely associated with stage IIIB, while IC-LNI patients have a survival more similar to stage IIB. Reclassifying stages IIB/IIA in IC- and EC-LNI, homogeneity of the TNM model increases (log-rank Chi square increases from 372.8 to 379.7; df[8]). EC-LNI is associated with worse survival compared to IC-LNI. In current UICC stages IIB/IIIA, EC-LNI patients show survival rates that are more closely associated with stage IIIB, while IC-LNI patients have a survival more similar to stage IIB. In future adaptations of the staging system for oesophageal cancer, EC-LNI vs IC-LNI should be considered. All authors have declared no conflicts of interest.
- 1 July 2013
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (suppl_1) , S2
Open AccessB-005CAN EXTRACAPSULAR LYMPH NODE INVOLVEMENT BE A TOOL TO FINETUNE PN1 FOR ADENOCARCINOMA IN INTERNATIONAL UNION AGAINST CANCER TNM 7TH EDITION?
The current (7th) International Union Against Cancer (UICC) pN staging system is based on the number of positive lymph nodes but does not take into consideration characteristics of the metastatic lymph nodes itself. The aim of the current study was to examine the prognostic value of extracapsular (EC-LNI) and intracapsular (IC-LNI) lymph node involvement in oesophageal cancer. From 1990-2010, 792 adenocarcinoma patients with primary R0 resection were retrieved from our prospective database. The number of resected lymph nodes, number of positive lymph nodes and number of EC-LNI/IC-LNI were determined. Extracapsular spread was defined as infiltration of cancer cells beyond the capsule of the positive lymph node. Four hundred and eight (51.5%) patients had positive lymph nodes. In 227 (55.6%) cases EC-LNI was detected. EC-LNI showed significantly worse cancer-specific 5-year survival compared to IC-LNI, 20.5% vs 40.7% (P < 0.0001). In the pN1-category (1 or 2 positive LNs–UICC stages IIB and IIIA) this was 30.2% vs 48.8%; P = 0.0035). In higher UICC stages, this effect was no longer noticed. UICC stages IIB/IIIA, EC-LNI patients show survival rates that are more closely associated with stage IIIB, while IC-LNI patients have a survival more similar to stage IIB. Reclassifying stages IIB/IIA in IC- and EC-LNI, homogeneity of the TNM model increases (log-rank Chi square increases from 372.8 to 379.7; df[8]). EC-LNI is associated with worse survival compared to IC-LNI. In current UICC stages IIB/IIIA, EC-LNI patients show survival rates that are more closely associated with stage IIIB, while IC-LNI patients have a survival more similar to stage IIB. In future adaptations of the staging system for oesophageal cancer, EC-LNI vs IC-LNI should be considered. All authors have declared no conflicts of interest.
- 20 May 2010
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (15) , e14505
Early metabolic response evaluation on PET-CT after a single cycle of chemotherapy in patients with cT3-4N0/+ oesophageal or GE-junction cancer subsequently treated by neoadjuvant chemoradiotherapy.
E14505 Background: To assess the value of early metabolic response with 18-FDG-PET-CT after one cycle of chemotherapy as a tool to predict pathological response and outcome in patients with locally advanced cancer of the oesophagus and GE-junction (GEJ) undergoing subsequent neoadjuvant chemoradiotherapy (nCRT). Methods: In a prospective, blinded study from 2004 – 2008 a total of 55 patients with cT3-4 N0/+ cancer of the oesophagus (n = 42) and GEJ (n = 13), underwent a PET-CT at baseline, 2 weeks after a single cycle of 5FU/cisplatinum (interval PET) and after completion of nCRT (5FU/cisplatinum first and last week of RT: 45 Gy in 25 fractions) (late PET). Patients showing signs of progressive disease (n = 8) were excluded from oesophagectomy. Early metabolic response (mR), late mR and complete mR were defined by a decrease in mean SUV of ≥ 35%, ≥ 50% and 100% respectively. The Mandard tumor regression (TRG) scoring system was used to score pathological response (pR). Cancer- specific survival (CSS) and time-to-recurrence (TTR) rates were estimated by the Kaplan-Meier method. Results: Mean decrease in SUVmean of the tumor was 36.4 ± 29.3% on interval PET and 70.3 ± 27.0% after completion of nCRT. Early mR was identified in 26/55 (47.3%) patients. Early mR and late mR were not associated with longer CSS (p = 0.77 and 0.61 respectively) and TTR (p = 0.49 and 0.57 respectively). A significant difference in CSS (p = 0.03) but not in TTR (p 0.74) was found in patients who had complete metabolic regression on late PET (n = 14). Good pR (TRG1 and TRG2) was shown in 54.3% of resected tumors. PPV and NPV for early mR in relation to good pR were 60% and 52% respectively. Conclusions: A decrease in SUVmean of ≥ 35% on PET-CT after one cycle of chemotherapy is not a good predictor of pR and outcome in patients with locally advanced oesophageal cancer subsequently treated by nCRT. Only complete mR after completion of CRT seems to have a significant prognostic value. Refinement and validation of trial-specific cut-off criteria for metabolic response evaluation is necessary. No significant financial relationships to disclose.
- 20 May 2010
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (15) , e14505
Early metabolic response evaluation on PET-CT after a single cycle of chemotherapy in patients with cT3-4N0/+ oesophageal or GE-junction cancer subsequently treated by neoadjuvant chemoradiotherapy.
E14505 Background: To assess the value of early metabolic response with 18-FDG-PET-CT after one cycle of chemotherapy as a tool to predict pathological response and outcome in patients with locally advanced cancer of the oesophagus and GE-junction (GEJ) undergoing subsequent neoadjuvant chemoradiotherapy (nCRT). Methods: In a prospective, blinded study from 2004 – 2008 a total of 55 patients with cT3-4 N0/+ cancer of the oesophagus (n = 42) and GEJ (n = 13), underwent a PET-CT at baseline, 2 weeks after a single cycle of 5FU/cisplatinum (interval PET) and after completion of nCRT (5FU/cisplatinum first and last week of RT: 45 Gy in 25 fractions) (late PET). Patients showing signs of progressive disease (n = 8) were excluded from oesophagectomy. Early metabolic response (mR), late mR and complete mR were defined by a decrease in mean SUV of ≥ 35%, ≥ 50% and 100% respectively. The Mandard tumor regression (TRG) scoring system was used to score pathological response (pR). Cancer- specific survival (CSS) and time-to-recurrence (TTR) rates were estimated by the Kaplan-Meier method. Results: Mean decrease in SUVmean of the tumor was 36.4 ± 29.3% on interval PET and 70.3 ± 27.0% after completion of nCRT. Early mR was identified in 26/55 (47.3%) patients. Early mR and late mR were not associated with longer CSS (p = 0.77 and 0.61 respectively) and TTR (p = 0.49 and 0.57 respectively). A significant difference in CSS (p = 0.03) but not in TTR (p 0.74) was found in patients who had complete metabolic regression on late PET (n = 14). Good pR (TRG1 and TRG2) was shown in 54.3% of resected tumors. PPV and NPV for early mR in relation to good pR were 60% and 52% respectively. Conclusions: A decrease in SUVmean of ≥ 35% on PET-CT after one cycle of chemotherapy is not a good predictor of pR and outcome in patients with locally advanced oesophageal cancer subsequently treated by nCRT. Only complete mR after completion of CRT seems to have a significant prognostic value. Refinement and validation of trial-specific cut-off criteria for metabolic response evaluation is necessary. No significant financial relationships to disclose.
- 1 October 2007
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (8) , 2659-2662
The Importance of Lymphocytes in Lung Ischemia-Reperfusion Injury
- 1 October 2007
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (8) , 2659-2662
The Importance of Lymphocytes in Lung Ischemia-Reperfusion Injury
- 1 June 2004
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 21 (Supplement) , 163-164
Beta-adrenergic stimulation of alveolar liquid clearance: a novel strategy to resolve pulmonary edema after lung transplantation?
- 1 June 2004
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 21 (Supplement) , 163-164
Beta-adrenergic stimulation of alveolar liquid clearance: a novel strategy to resolve pulmonary edema after lung transplantation?
- 1 October 2001
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 14 (3) , 173-177
Gastroplasty: yes or no to gastric drainage procedure.
- 1 October 2001
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 14 (3) , 173-177
Gastroplasty: yes or no to gastric drainage procedure.
- 1 January 2000
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 55 (3) , 154-162
Lung Volume Reduction Surgery (Lvrs) For Emphysema: Initial Experience at the University Hospital Gasthuisberg
Emphysema is a disabling disease, for which there is no curative therapy available today. Lung transplantation offers a valuable option for a very selected number of patients, however, due to the enormous organ shortage, only few patients can be offered such a therapy. Recently there has been important resurgence of interest in lung volume reduction surgery and as a consequence, we have embarked in such a program since may 1997. We have now performed unilateral lung volume reduction surgery in 29 emphysema patients (25 on the right and 4 on the left side). Twenty-four patients were already discharged home. There has been no perioperative mortality. The mean hospital stay was 19.8 ±11.4 days (range, 8-47 d). Twenty patients of whom we already have follow-up data during 6 months (m) form the further basis of this report. Six weeks after the procedure the FEV1 increased from 0.82 ± 0.28 L (28 ± 8%) to 1.05 ± 0.39 L, a mean increase of 28%. There was a further increase of the FEV1 to a maximum of 1.06 ± 0.42 L at 6 m, a mean maximum increase of 29% (p=0.0046, ANOVA). Sim-ilarly, the FVC increased from 2.80±1.10Lto3.15± 1.00 L, a mean increase of 12.5%. A further increase was also obtained at 6 m and was 19.6% (3.35 ± 1.05 L, p=0.014, ANOVA). The maximum decrease in RV was obtained at 3 m (from 5.91 ± 1.37 L to 4.37 ± 0.85 L (p=0.0001, ANOVA), a mean decrease of 26%. The maximum TLC decrease was demonstrated at 3 m (from 8.71 ± 1.71 L to 7.60 ± 1.56 L (p=0.002, ANOVA), a mean decrease of 12.8%. Afterwards there was again a gradual raise of the TLC. The six minute walking distance increased from 231 ±31 m to 272 ± 34 m (p=NS) after pulmonary rehabilitation and to 416 i 77 in at 3 m and 415 ± 18 m at 6 m (p=0.0002, ANOVA) after the operation. The quality of life (measured with a standardized questionnaire, the Nottingham Health Profile ) improved significantly in several domains (e.g. mobility, pain, energy, emotions and social) at 3 m postoperatively. There was one late death (at 6 m) due to an unknown cause. The actuarial survival rate was therefore 100% at 3 m and 95% at 12 m. In conclusion, unilateral thoracoscopic lung volume reduction surgery is a new and safe treatment modality for patients suffering from severe end-stage emphysema. The objective and subjective improvement is marked and the mortality is very low. Rigid selection criteria are, however, necessary to be able to guarantee an optimal result.
- 1 January 2000
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 55 (3) , 154-162
Lung Volume Reduction Surgery (Lvrs) For Emphysema: Initial Experience at the University Hospital Gasthuisberg
Emphysema is a disabling disease, for which there is no curative therapy available today. Lung transplantation offers a valuable option for a very selected number of patients, however, due to the enormous organ shortage, only few patients can be offered such a therapy. Recently there has been important resurgence of interest in lung volume reduction surgery and as a consequence, we have embarked in such a program since may 1997. We have now performed unilateral lung volume reduction surgery in 29 emphysema patients (25 on the right and 4 on the left side). Twenty-four patients were already discharged home. There has been no perioperative mortality. The mean hospital stay was 19.8 ±11.4 days (range, 8-47 d). Twenty patients of whom we already have follow-up data during 6 months (m) form the further basis of this report. Six weeks after the procedure the FEV1 increased from 0.82 ± 0.28 L (28 ± 8%) to 1.05 ± 0.39 L, a mean increase of 28%. There was a further increase of the FEV1 to a maximum of 1.06 ± 0.42 L at 6 m, a mean maximum increase of 29% (p=0.0046, ANOVA). Sim-ilarly, the FVC increased from 2.80±1.10Lto3.15± 1.00 L, a mean increase of 12.5%. A further increase was also obtained at 6 m and was 19.6% (3.35 ± 1.05 L, p=0.014, ANOVA). The maximum decrease in RV was obtained at 3 m (from 5.91 ± 1.37 L to 4.37 ± 0.85 L (p=0.0001, ANOVA), a mean decrease of 26%. The maximum TLC decrease was demonstrated at 3 m (from 8.71 ± 1.71 L to 7.60 ± 1.56 L (p=0.002, ANOVA), a mean decrease of 12.8%. Afterwards there was again a gradual raise of the TLC. The six minute walking distance increased from 231 ±31 m to 272 ± 34 m (p=NS) after pulmonary rehabilitation and to 416 i 77 in at 3 m and 415 ± 18 m at 6 m (p=0.0002, ANOVA) after the operation. The quality of life (measured with a standardized questionnaire, the Nottingham Health Profile ) improved significantly in several domains (e.g. mobility, pain, energy, emotions and social) at 3 m postoperatively. There was one late death (at 6 m) due to an unknown cause. The actuarial survival rate was therefore 100% at 3 m and 95% at 12 m. In conclusion, unilateral thoracoscopic lung volume reduction surgery is a new and safe treatment modality for patients suffering from severe end-stage emphysema. The objective and subjective improvement is marked and the mortality is very low. Rigid selection criteria are, however, necessary to be able to guarantee an optimal result.